Jury Hands J&J, Bayer Win In 3rd Xarelto Bellwether

Law360, New York (August 18, 2017, 9:52 PM EDT) -- A Mississippi federal jury on Friday sided with Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. in a bellwether case brought by a woman claiming the blood thinner Xarelto caused gastrointestinal bleeding that required her hospitalization, according to the plaintiff’s and defendants’ representatives.

The trial was the third win for Janssen and Bayer in a bellwether trial in Louisiana multidistrict litigation over claims they didn't warn about the possibility of dangerous internal bleeding associated with the blood thinner. (AP) The trial was...
To view the full article, register now.

Related

Sections

Case Information

Case Title

In Re: Xarelto (Rivaroxaban) Products Liability Litigation


Case Number

2:14-md-02592

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Eldon E. Fallon

Date Filed

December 12, 2014


Case Title

Mingo v. Janssen Research & Development LLC et al


Case Number

2:15-cv-03469

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Eldon E. Fallon

Date Filed

August 14, 2015

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.